Organizer
Technology Networks
Technology Networks
Technology Networks explores the science that matters to you, providing access to the latest scientific news, products, research, videos and posters.Technology Networks is part of LabX Media Group, which also owns Lab Manager, LabX, and The Scientist. Technology Networks offer today's scientist a single resource that contains unique, engaging, and entertaining content from their field of research.
Tags
LC/MS
LC/MS/MS
LC/TOF
Ion Mobility
LC/HRMS
LinkedIn Logo

Discovery of Lipid Biomarkers for Parkinson’s Disease Using TIMS Mass Spectrometry

RECORD | Already taken place Th, 9.3.2023
Dr. Roberts will highlight how his work aims to identify disease-specific lipid isomers that can be used for the early detection and diagnosis of PD, using ion mobility mass spectrometry.
Go to the webinar
Technology Networks: Discovery of Lipid Biomarkers for Parkinson’s Disease Using TIMS Mass Spectrometry
Technology Networks: Discovery of Lipid Biomarkers for Parkinson’s Disease Using TIMS Mass Spectrometry

Parkinson’s disease (PD) is a neurodegenerative disease that affects 10 million people worldwide. In this webinar, Dr. Roberts will present his research into how lipids may be used as biomarkers for PD.

Changes in the ratios of isomeric lipids, which vary in the position of the double bond or arrangement of the fatty acid chains, have been proven to be useful biomarkers in other diseases including cancer and type 2 diabetes. As lipids are altered in the plasma of PD patients, this is evidence that lipids could be valuable biomarkers for the disease.

In this webinar, Dr. Roberts will highlight how his work aims to identify disease-specific lipid isomers that can be used for the early detection and diagnosis of PD, using ion mobility mass spectrometry.

Attend this webinar to:

  • Understand the evidence that suggests lipids could be a valuable biomarker in PD
  • Learn about the complexity of lipid metabolism in PD and how Dr. Roberts’ research measures specific lipids
  • Discover how TIMS can be used to identify disease-specific lipid isomers for the early detection of PD

Presenter: Dr. Blaine Roberts (Associate Professor Department of Biochemistry, Emory University)

Technology Networks
LinkedIn Logo
 

Related content

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Metabolomics

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Environmental

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Environmental

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/HRMS, Particle characterization, LC/IT
Manufacturer
Waters
Industries
Lipidomics

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector

Applications
| 2025 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Environmental
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike